¡¡¡¡ÔÚ×î½üÒ»ÏîÑо¿ÖУ¬¿ÆÑ§¼ÒÃÇ·¢ÏÖÁËÉöÔàÖØÒªµÄϸ°ûÐźÅͨ·£¬°ÐÏò¸ÃÐźÅͨ·»òÐí¿ÉÒÔ³ÉΪÖÎÁÆÂýÐÔÉöÔ༲²¡ÒÔ¼°ÆäËûÖÂÃü¼²²¡£¨°üÀ¨ÐÄÔಡºÍÖз磩µÄ¹Ø¼ü¡£
¡¡¡¡Óɲ¼Àï˹ÍдóѧÁìµ¼µÄÕâÏîÑо¿·¢±íÔÚ×î½üµÄ¡¶PNAS¡·ÔÓÖ¾ÉÏ£¬Ñо¿ÕßÃÇÔÚÉöÔàÖмø¶¨³öÒ»ÖÖ½Ð×öÉñ¾ëÄY£¨Npy£©µÄÎïÖÊ¡£¿ÆÑ§¼ÒÔÚ³ÆÎª×ãϸ°ûÖз¢ÏÖÁËNpy£¬¸Ãϸ°ûͨ¹ý·¢ËÍÓк¦ÐźÅËð»µÉöСÇò£¬²¢µ¼Ö´óÁ¿µ°°×ÖÊй©µ½ÄòÒºÖУ¬×îÖÕ³öÏÖµ°°×ÄòÖ¢×´¡£Í¨³£ÕâÖÖ¼²²¡ÔÚÔçÆÚµÃ²»µ½Õï¶Ï£¬Èç¹û²»¼ÓÒÔÖÎÁÆ£¬»áµ¼ÖÂÉö¹¦ÄÜË¥½ß£¬ÐèҪ͸Îö»ò½øÐÐÉöÔàÒÆÖ²ÔÚÄܹ»Î¬³Ö½¡¿µ¡£´ËÍ⣬¸Ã¼²²¡»¹Ó뻼ÐÄÔಡ»òÖзçµÄ·çÏÕÔö¼ÓÓйء£
¡¡¡¡ÎªÁ˸üºÃµØÁ˽âNpyÔÚÉöÔàÖеÄÖØÒªÐÔ£¬¸ÃÑо¿Ð¡×éÑо¿ÁËNpyȱÏÝÐÍСÊó¡£Ñо¿½á¹û±íÃ÷£¬È±·¦NpyµÄСÊó»áÊܵ½ÌÇÄò²¡ºÍ·ÇÌÇÄò²¡ÐÔÉöÔ༲²¡µÄ±£»¤¡£Õâ±íÃ÷ÉöСÇòNpy±í´ïÁ¿µÄ¾Ö²¿Ï½µÊµ¼ÊÉÏÊÇÒ»ÖÖ±£»¤»úÖÆ£¬¿É¼õÉÙÆä¶ÔÉöÔàµÄËðÉË¡£
¡¡¡¡½øÒ»²½£¬Ñо¿ÈËÔ±·¢ÏÖNpyͨ¹ý³ÆÎªNpy Receptor 2£¨Npy-2R£©µÄϸ°ûÊÜÌå·¢»Ó×÷Óá£ÔÚÈ·¶¨ÁËÈ·ÇеķÖ×Ó;¾¶ºó£¬ËûÃÇÏ£ÍûÕÒµ½Ò»ÖÖ¸ÉÔ¤Æä»îÐԵķ½·¨¡£Í¨¹ý¸ø»¼ÓÐÉöÔ༲²¡µÄСÊóÌṩÁËÒ»ÖÖ×è¶ÏNpy-2RµÄÒ©ÎʹСÊóµÄÉöÔ༲²¡ÑÏÖØ³Ì¶ÈϽµ¡£
¡¡¡¡Coward½ÌÊÚ˵£º¡°ÕâÊÇÒ»¸ö·Ç³£ÁîÈËÐ˷ܵÄÍ»ÆÆ£¬ÎÒÃÇÆÚ´ý×ÅÔÚδÀ´µÄÑо¿ÖÐÍÆ½øÕâÏîÖÁ¹ØÖØÒªµÄ¹¤×÷¡£¡±
¡¡¡¡×ÊѶ³ö´¦£ºBlocking brain signals detected in the kidney could help unlock future treatments for kidney failure
¡¡¡¡Ôʼ³ö´¦£ºAbigail C. Lay el al.£¬ "A role for NPY-NPY2R signaling in albuminuric kidney disease£¬" PNAS (2020). www.pnas.org/cgi/doi/10.1073/pnas.2004651117
ºÜ¶àÉöË¥½ß»¼Õß¶¼ÓÐÕâÑùµÄ¾õÎò£ºÒûʳ·½ÃæÔÙ²»ÄÜËæÐÄËùÓûÁË¡£µ«ÕýÓÉÓÚ²¿·Ö»¼Õß¶ÔÒûʳÎÊÌâµÄ¹ý¶È¹Ø×¢¶ø²»É÷×ß½øÎóÇø¡£ÉõÖÁÓл¼Õß¼á³Ö¡°µÎÑβ»½ø¡±¡£ÉöË¥½ß»¼Õßµ½µ×Ó¦¸ÃÈçºÎ¶Ô´ý¡°½ûÑΡ±ºÍ¡°ÏÞË®¡±£¿±¾ÆÚ¡°½¡¿µÁ÷ÑÔÖÕ½áÕߣ¬39½¡¿µÍøÌرðÑûÇëÁ˹ãÖÝÊеÚÒ»ÈËÃñÒ½Ôº´óÄÚ¿ÆÖ÷ÈμæÉöÄÚ¿ÆÖ÷Èθµ¾ýÖÛÀ´Ïû³ýÎÒÃǵÄÒÉ»ó¡£